EMA Custom Webtools Rating widget: Hidden by field_ema_hide_rating for this node.
Cardiovascular diseases
This page brings together the European Medicines Agency's (EMA) latest information on diseases affecting the heart and blood vessels.
It lists the following:
- The newest and most recently updated medicines authorised for cardiovascular diseases in the European Union
- EMA's latest news announcements related to cardiovascular diseases
- EMA's upcoming events on cardiovascular topics
We are currently unable to display the new and recently updated medicines authorised for cardiovascular disease due to a technical error. We are working to resolve the issue as soon as possible. We apologise for any inconvenience caused.
Latest news
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 December 2023
EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its December 2023 meeting.
15 December 2023
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine.
1 December 2023
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023
EMA’s human medicines committee (CHMP) recommended eight medicines.
10 November 2023
Events of interest
Currently, we have no events for this therapeutic area.